Firm's Home Health Monitoring System Provides the 'Most Comprehensive Offering in the Telehealth Space'
Source: Streetwise Reports  (8/26/20)
As the Covid pandemic accelerates the adoption of telemedicine technology, Reliq Health Technologies' recent contracts represent exponential growth. More >

Fluidigm Shares Climb 34% After FDA Authorizes Saliva-Based COVID-19 Test
Source: Streetwise Reports  (8/26/20)
Fluidigm Corp. shares reached a new 52-week high after the firm reported the FDA granted Emergency Use Authorization for saliva-based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19. More >

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20
Source: Streetwise Reports  (8/14/20)
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. More >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks
Source: Matt Badiali for Streetwise Reports  (8/10/20)
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. More >

US Immunology Firm Lands Government Contract, Raises Cash
Source: Streetwise Reports  (8/5/20)
These two CytoSorbents events are discussed in a Dawson James report. More >

Tech Firm Explains Key Feature of its Contact Tracing Solution
Source: Streetwise Reports  (8/5/20)
Loop Insights' technology lacks the adoption challenges that app-based solutions face. More >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue
Source: Streetwise Reports  (8/5/20)
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. More >

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients
Source: Streetwise Reports  (8/4/20)
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. More >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'
Source: Streetwise Reports  (7/29/20)
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. More >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'
Source: Streetwise Reports  (7/22/20)
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. More >

Cheap Valuation and Fastest Revenue Growth in Telemedicine? Analyst Says Yes.
Source: Peter Epstein for Streetwise Reports  (7/17/20)
In the time of Covid-19, Peter Epstein of Epstein Research breaks down the investment opportunity offered by CloudMD. More >

Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400%
Source: Streetwise Reports  (7/15/20)
Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients. More >

Biotech Partners to Develop, Offer Alzheimer's Disease Tests
Source: Streetwise Reports  (7/13/20)
ProMIS Neurosciences and its collaborator make their relationship official with a joint venture agreement. More >

Preclinical COVID-19 Vaccine Data 'Encouraging'
Source: Streetwise Reports  (7/8/20)
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report. More >

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX
Source: Streetwise Reports  (6/22/20)
Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. More >

Biotech Makes 'Significant Progress' Creating Highly Accurate COVID-19 Antibody Test
Source: Streetwise Reports  (6/17/20)
ProMIS Neurosciences states that the current version of the ProMIS-BCNI assay achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2, the coronavirus causing COVID-19. More >

Mackie Research: Small Cap a World Leader in Health and Safety Wearables
Source: Bill Newman of Mackie Research for Streetwise Reports  (6/5/20)
Mackie Research believes Blockchain Holdings' TraceSafe tracking platform could tap into the "exceptionally large market" for contact tracing during the Covid-19 pandemic. More >

AI Firm Receives Grant to Create Deep Learning Tools to Enhance Organ Donation Processes
Source: Streetwise Reports  (6/3/20)
Xtract AI has secured a CA$150,000 grant from the Innovative Solutions Canada program to utilize artificial intelligence to increase organ donations and improve transplant success rates. More >

AI Firm Develops Tool That Helps Radiologists Diagnose COVID-19
Source: Streetwise Reports  (5/30/20)
Patriot One Technologies and its partners have created a model that automatically calculates, from a radiological scan, the degree of a patient's affected lungs, a COVID-19 indicator. More >

Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists
Source: Streetwise Reports  (5/27/20)
Imagin Medical delivered two functional i/Blueâ„¢ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists. More >

Biotech Partnership to Develop Diagnostic Assay for Alzheimer's Disease
Source: Streetwise Reports  (5/20/20)
With its work on this and a SARS-CoV-2 test, ProMIS Neurosciences is applying its technology platform in new ways. More >

Surgical Imaging Company Provides Update on COVID-19 Impact
Source: Streetwise Reports  (5/18/20)
Imagin Medical reported that its actions have mitigated the impact of the coronavirus on its business operations. More >

Biotech Expands Antibody Research Across Multiple Neurodegenerative Diseases and Covid-19
Source: Streetwise Reports  (5/14/20)
ProMIS Neurosciences advances its various antibody programs related to neurodegenerative diseases and viral infections such as Covid-19. More >

Biotech Advances Accurate SARS CoV-2 Antibodies Detection Test
Source: Streetwise Reports  (5/13/20)
Testing and validation of ProMIS Neurosciences' antibody targets will be conducted over the coming weeks. More >

US Counties to Use Tech Firm's Software for COVID-19 Contact Tracing
Source: Streetwise Reports  (4/29/20)
Demand has been taking off for HealthSpace Data Systems' platform released two weeks ago. More >